Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy
Yan Li,Yuxin Bai,Sujiao Ni,Yao Deng,Chang Liu,Qiancheng Liu,Haiming Zou,Daifan Yue,Dongsheng Wang,Dongming Zheng,Kai-Hua Zhang,Lichun Wu,Linlan Yang,Han Ling,Bo Ye
DOI: https://doi.org/10.2147/IJN.S436373
IF: 7.033
2023-11-01
International Journal of Nanomedicine
Abstract:Abstract In addition to hemostasis and coagulation, years of studies have proved that platelets are involved in the whole process of tumor progression, including tumor invasion, intravasation, extravasation, and so on. It means that this property of platelets can be used in anti-tumor therapy. However, traditional platelet-based antitumor drugs often cause autologous platelet damage due to lack of targeting, resulting in serious side effects. Therefore, the researchers designed a variety of anti-tumor drug delivery systems based on platelets by targeting platelets or platelet membrane coating. The drug delivery systems have special response modes, which is crucial in the design of nanoparticles. These modes enhance the targeting and improve the anti-tumor effect. Here, we present a review of recent discoveries in the field of the crosstalk between platelets and tumors and the progress of platelet-based anti-tumor nanoparticles.
Medicine,Materials Science